PR

Priyanka Rohatgi

Biotech Investor, CEO, Strategic Business Advisor, Company Builder

Greater Boston

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Research and Development (R&D)
Regulatory Submissions
Financial Modeling
Business Strategy
Analytical Skills
Project Management
Co-creation
Private Equity
Pharmaceutics
Oncology
Corporate Development
Entrepreneurship
Investments
Due Diligence
Business Development
Leadership
Incubators
Corporate Venture Capital
Venture Capital
Pharmaceutical Industry

Education

Lists including Priyanka

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

PNR Ventures and Advisor

2024

  • Founder and CEO

    2024

NH
Novo Holdings

2022

  • Partner

    2022

IB
Interius BioTherapeutics

2021 - 2022

  • Board Observer

    2021 - 2022

LF
Longwood Fund

2021 - 2022

  • Venture Partner

    2021 - 2022

XT
Xilio Therapeutics, Inc.

2020 - 2021

  • Board Observer

    2020 - 2021

PO
Pyxis Oncology

2019 - 2021

  • Board Member

    2019 - 2021

I
Ipsen

2018 - 2021

  • Managing Director, Head of Ipsen Ventures

    2018 - 2021

A
AbbVie

2016 - 2018

  • Investment Director, AbbVie Ventures

    2016 - 2018

Mirna Therpeutics

2015 - 2016

  • Board Member

    2015 - 2016

OI
Opsonix, Inc.

2014 - 2015

  • Board Member

    2014 - 2015